Kenvue Inc. logo

Kenvue Inc. (J4D)

Market Open
2 Mar, 20:00
XMUN XMUN
16. 07
+0.1
+0.63%
- Market Cap
21.62 P/E Ratio
0.8% Div Yield
0 Volume
1.14 Eps
15.97
Previous Close
Day Range
16.07 16.1
Year Range
11.83 23.18
Want to track J4D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KVUE earnings report is expected in 64 days (6 May 2026)

Summary

J4D trading today higher at €16.07, an increase of 0.63% from yesterday's close, completing a monthly increase of 10.54% or €1.53. Over the past 12 months, J4D stock gained 9.44%.
J4D pays dividends to its shareholders, with the most recent payment made on Feb 25, 2026. The next estimated payment will be in In 2 months on May 25, 2026 for a total of €0.2075.
The last earnings report, released on Feb 17, 2026, exceeded the consensus estimates by 0.05%. On average, the company has fell short of earnings expectations by -0.06%, based on the last three reports. The next scheduled earnings report is due on May 06, 2026.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

J4D Chart

Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal

Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal

KVUE reports solid Q4 results, with margin gains and broad-based global growth, while moving closer to its planned Kimberly-Clark acquisition.

Zacks | 1 week ago
Kenvue tops Q4 forecasts as Kimberly-Clark deal advances

Kenvue tops Q4 forecasts as Kimberly-Clark deal advances

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring steps ahead of its planned combination with Kimberly-Clark. For Q4, Kenvue posted adjusted earnings per share of $0.27, beating analyst estimates of $0.22.

Proactiveinvestors | 1 week ago
Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam

Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam

Kenvue (NYSE: KVUE) reported fourth-quarter results yesterday that exceeded analyst expectations, with adjusted EPS of $0.27 beating the FactSet estimate of $0.22 by 23%.

247wallst | 1 week ago

Kenvue Inc. (J4D) FAQ

What is the stock price today?

The current price is €16.07.

On which exchange is it traded?

Kenvue Inc. is listed on XMUN.

What is its stock symbol?

The ticker symbol is J4D.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on May 06, 2026.

Has Kenvue Inc. ever had a stock split?

No, there has never been a stock split.

Kenvue Inc. Profile

Household Products Industry
Consumer Staples Sector
Kirk L. Perry CEO
XMUN Exchange
US49177J1025 ISIN
US Country
22,000 Employees
11 Feb 2026 Last Dividend
- Last Split
4 May 2023 IPO Date

Overview

Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.

Products and Services

  • Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
  • Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
  • Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.

Contact Information

Address: 199 Grandview Road
Phone: (732) 524-0400